Related Experiment Video
Updated: Sep 19, 2026

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
Keratin 8 Destabilization via O-GlcNAcylation Promotes Insulin Resistance in metabolic dysfunction associated
Long Teng1, Ling Luo1, Jiaming Lai1
1Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, No. 58 Zhongshan II Road, Yuexiu District, Guangzhou, China.
Background:
Keratin 8 (K8) serves as a core component of intermediate filaments within the hepatocellular cytoskeleton, with its functionality critically regulated by post-translational modifications. O-GlcNAcylation critically participates in liver disease progression. This study aimed to identify the O-GlcNAcylation sites on K8 and elucidate their roles and molecular mechanisms in MASLD.
Methods:
Using genetically modified (K8-deficient) and high-fat diet-induced MASLD mice, along with palmitic acid-treated hepatocytes, we assessed K8 O-GlcNAcylation dynamics and filament stability via immunoblotting, affinity assays, co-immunoprecipitation, and O-linked HexNAc proteomic analysis. Metabolic parameters and mTOR/PI3K/AKT signaling were evaluated. Viral vectors mediating K8 knockdown and S9A-mutant or wild-type K8 replacement were employed for site-directed mutagenesis studies.
Results:
MASLD models showed elevated K8 O-GlcNAcylation and increased O-GlcNAc transferase expression. Proteomics identified Ser9 as the key modification site. Ser9 O-GlcNAcylation destabilized K8 filaments, increased soluble K8, and suppressed mTOR/PI3K/AKT phosphorylation. S9A-K8 mutation reduced O-GlcNAcylation, restored cytoskeletal stability and insulin signaling, and improved glucose tolerance and hepatic steatosis.
Conclusions:
Ser9-dependent K8 O-GlcNAcylation drives MASLD-associated insulin resistance by disrupting cytoskeletal integrity and impairing insulin signaling. Targeting this modification site restores metabolic disorders, providing a potential novel therapeutic target for MASLD.
Related Concept Videos
Type II Diabetes II: Pathophysiology
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Chronic Pancreatitis II: Pathophysiology
Proteoglycans
Insulin: The Receptor and Signaling Pathways
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...

